This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/89357
The final accepted version (not copyedited yet) is in this tab.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Harnessing Digital Innovation for Diabetes Care: Insights from the Action4Diabetes–CorrelAid Data4Good Collaboration
ABSTRACT
Recent decades have seen a dramatic proliferation of real-world data use and evidence generation from non-research settings. Data utilisation is particularly revolutionising the operations and impact of non-governmental organisations worldwide, especially in low- and middle-income countries. Action4Diabetes, which has incrementally been providing sustainable diabetes care for children, adolescents and young adults with type 1 diabetes (aged 0-25 years) across South-east Asia since 2015, is one such organisation. Recognising the importance of data, Action4Diabetes have collaborated with CorrelAid e.V. As part of this, Action4Diabetes has been exchanging patient data with the local program hospitals monthly. A preprocessing pipeline was implemented, extracting patient and medical product data in a standardised and unified manner. Data collected are anonymized and subsequently uploaded to secure public cloud storage, where it is processed and stored in a centralized database. The model employed by Action4Diabetes shows that much can be achieved and can perhaps be utilised elsewhere.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.